CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Mar. 29, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	[1]	$ 2,151	$ 1,305	[2]
Short-term investments	[1]	8,199	8,525
Trade accounts receivable, less allowance for doubtful accounts: 2020—$527; 2019—$527	[1]	9,881	8,724
Inventories	[1],[3]	8,423	8,283
Current tax assets	[1]	3,346	3,344
Other current assets	[1]	2,737	2,622
Total current assets	[1]	34,738	32,803
Equity-method investments	[1]	15,524	17,133
Long-term investments	[1]	2,696	3,014
Property, plant and equipment, less accumulated depreciation: 2020—$16,929; 2019—$16,789	[1]	14,040	13,967
Identifiable intangible assets, less accumulated amortization	[1],[4]	34,464	35,370
Goodwill	[1]	58,502	58,653
Noncurrent deferred tax assets and other noncurrent tax assets	[1]	2,207	2,099
Other noncurrent assets	[1]	4,166	4,450
Total assets	[1]	166,336	167,489
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2020—$337; 2019—$1,462	[1]	16,007	16,195
Trade accounts payable	[1]	3,972	4,220
Dividends payable	[1]	0	2,104
Income taxes payable	[1]	1,150	980
Accrued compensation and related items	[1]	2,246	2,720
Other current liabilities	[1]	10,515	11,083
Total current liabilities	[1]	33,890	37,304
Long-term debt	[1]	36,281	35,955
Pension benefit obligations, net	[1]	5,442	5,638
Postretirement benefit obligations, net	[1]	1,093	1,124
Noncurrent deferred tax liabilities	[1]	5,268	5,578
Other taxes payable	[1]	12,212	12,126
Other noncurrent liabilities	[1]	6,812	6,317
Total liabilities	[1]	100,998	104,042
Commitments and Contingencies	[1]
Preferred stock	[1]	17	17
Common stock	[1]	470	468
Additional paid-in capital	[1]	87,680	87,428
Treasury stock	[1]	(111,010)	(110,801)
Retained earnings	[1]	101,000	97,670
Accumulated other comprehensive loss	[1]	(13,131)	(11,640)
Total Pfizer Inc. shareholders’ equity	[1]	65,026	63,143
Equity attributable to noncontrolling interests	[1]	312	303
Total equity	[1],[5]	65,338	63,447
Total liabilities and equity	[1]	$ 166,336	$ 167,489

[1] Amounts may not add due to rounding.

[2] Amounts may not add due to rounding.

[3] The change from December 31, 2019 reflects increases for certain products, including inventory build for new product launches, market demand and network strategy, partially offset by a decrease due to foreign exchange.

[4] The decrease in Identifiable intangible assets, less accumulated amortization, is primarily due to amortization.

[5] Amounts may not add due to rounding.